Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
Bin Su, Stefania Dispinseri, Valeria Iannone, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
Yuanling Yu, Meiyu Wang, Xiao‐Ai Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 101
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Elise Landais, Penny L. Moore
Retrovirology (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 103
Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephen R. Walsh, Michael S. Seaman
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge
Irene N. Nkumama, Rodney Ogwang, Dennis Odera, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1215-1224.e6
Open Access | Times Cited: 7
HIV controllers: hope for a functional cure
Zhuoya Deng, Hongxia Yan, Olivier Lambotte, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference
Zenglei Hu, Jie Ni, Yongzhong Cao, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 222-222
Open Access | Times Cited: 40
The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein
Xuemin Chen, Christina A. Rostad, Larry J. Anderson, et al.
Virology (2021) Vol. 559, pp. 1-9
Open Access | Times Cited: 34
Chinese Guidelines for the Diagnosis and Treatment of HIV/AIDS (2021 Edition)

Infectious Diseases & Immunity (2022) Vol. 2, Iss. 3, pp. 145-167
Open Access | Times Cited: 22
Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
Charles D. Murin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 32
Development of plant-made monoclonal antibodies against viral infections
Qiang Chen
Current Opinion in Virology (2021) Vol. 52, pp. 148-160
Open Access | Times Cited: 31
Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis
Lucas Shores, Sean H. Kelly, Kelly M. Hainline, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 30
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat
David C. Montefiori, Maria V. Filsinger Interrante, Benjamin N. Bell, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 3
Open Access | Times Cited: 21
Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts
Zak A. Yaffe, Nicole E. Naiman, Jennifer A. Slyker, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 4, pp. 100254-100254
Open Access | Times Cited: 20
Pre-existing infant antibody-dependent cellular cytotoxicity associates with reduced HIV-1 acquisition and lower morbidity
Allison S. Thomas, Yvetane Moreau, Wenqing Jiang, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100412-100412
Open Access | Times Cited: 20
Utilizing immunotherapy towards achieving a functional cure for HIV-1
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole S. Søgaard
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 187-193
Closed Access | Times Cited: 2
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
Shuang Li, Christiane Moog, Tong Zhang, et al.
Chinese Medical Journal (2022)
Open Access | Times Cited: 11
Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV‐infected patients on antiretroviral therapy
Yan Liu, Zhen Li, Xiaofan Lu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 6
Biosafety and immunology: An interdisciplinary field for health priority
Jun Liu, Gary Wong, Huijun Li, et al.
Biosafety and Health (2024) Vol. 6, Iss. 5, pp. 310-318
Open Access | Times Cited: 1
A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity
Adonis A. Rubio, Maria V. Filsinger Interrante, Benjamin N. Bell, et al.
Journal of Virology (2021) Vol. 95, Iss. 15
Open Access | Times Cited: 11
Abnormal Shift in B Memory Cell Profile Is Associated With the Expansion of Circulating T Follicular Helper Cells via ICOS Signaling During Acute HIV-1 Infection
Xiaofan Lu, Xin Zhang, Allen Ka Loon Cheung, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
The current and future role of nanovaccines in HIV-1 vaccine development
Christopher P. Karch, Gary R. Matyas
Expert Review of Vaccines (2021) Vol. 20, Iss. 8, pp. 935-944
Open Access | Times Cited: 10
Breadth of Fc-mediated effector function delineates grades of clinical immunity following human malaria challenge
Irene N. Nkumama, Dennis Odera, Fauzia K. Musasia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
Maggie Jing Ouyang, Zhujun Ao, Titus Abiola Olukitibi, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 3
Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV
Ali Danesh, Yanqin Ren, R. Brad Jones
Current Opinion in HIV and AIDS (2020) Vol. 15, Iss. 5, pp. 316-323
Open Access | Times Cited: 8
Live unattenuated vaccines for controlling viral diseases, including COVID‐19
Jiming Chen
Journal of Medical Virology (2020) Vol. 93, Iss. 4, pp. 1943-1949
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top